Chen XF - Search Results

1

Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer.

Xu X, Huang YH, Li YJ, Cohen A, Li Z, Squires J, Zhang W, Chen XF, Zhang M, Huang JT. Xu X, et al. Among authors: chen xf. Asian J Androl. 2017 Nov-Dec;19(6):686-693. doi: 10.4103/1008-682X.191518. Asian J Androl. 2017. PMID: 27905327 Free PMC article.

2

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation.

Lipianskaya J, Cohen A, Chen CJ, Hsia E, Squires J, Li Z, Zhang Y, Li W, Chen X, Xu H, Huang J. Lipianskaya J, et al. Asian J Androl. 2014 Jul-Aug;16(4):541-4. doi: 10.4103/1008-682X.123669. Asian J Androl. 2014. PMID: 24589459 Free PMC article. Review.

3

p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma.

Li Z, Sun Y, Chen X, Squires J, Nowroozizadeh B, Liang C, Huang J. Li Z, et al. Mol Cancer Res. 2015 Mar;13(3):584-91. doi: 10.1158/1541-7786.MCR-14-0277-T. Epub 2014 Dec 15. Mol Cancer Res. 2015. PMID: 25512615 Free PMC article.

4

The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma.

Li W, Cohen A, Sun Y, Squires J, Braas D, Graeber TG, Du L, Li G, Li Z, Xu X, Chen X, Huang J. Li W, et al. Mol Cancer Res. 2016 Apr;14(4):344-53. doi: 10.1158/1541-7786.MCR-15-0466. Epub 2016 Feb 1. Mol Cancer Res. 2016. PMID: 26832214 Free PMC article.

5

All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy.

Yan Y, Li Z, Xu X, Chen C, Wei W, Fan M, Chen X, Li JJ, Wang Y, Huang J. Yan Y, et al. BMC Complement Altern Med. 2016 Mar 31;16:113. doi: 10.1186/s12906-016-1088-y. BMC Complement Altern Med. 2016. PMID: 27036550 Free PMC article.

6

Epigenetic therapy potential of suberoylanilide hydroxamic acid on invasive human non-small cell lung cancer cells.

Zhang S, Wu K, Feng J, Wu Z, Deng Q, Guo C, Xia B, Zhang J, Huang H, Zhu L, Zhang K, Shen B, Chen X, Ma S. Zhang S, et al. Oncotarget. 2016 Oct 18;7(42):68768-68780. doi: 10.18632/oncotarget.11967. Oncotarget. 2016. PMID: 27634890 Free PMC article.

7

Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells.

Lei K, Sun R, Chen LH, Diplas BH, Moure CJ, Wang W, Hansen LJ, Tao Y, Chen X, Chen CJ, Greer PK, Zhao F, Yan H, Bigner DD, Huang J, He Y. Lei K, et al. Sci Rep. 2018 Aug 21;8(1):12507. doi: 10.1038/s41598-018-30062-z. Sci Rep. 2018. PMID: 30131529 Free PMC article.

8

ATM deficiency promotes progression of CRPC by enhancing Warburg effect.

Xu L, Ma E, Zeng T, Zhao R, Tao Y, Chen X, Groth J, Liang C, Hu H, Huang J. Xu L, et al. Endocr Relat Cancer. 2019 Jan 1;26(1):59-71. doi: 10.1530/ERC-18-0196. Endocr Relat Cancer. 2019. PMID: 30400006 Free PMC article.

9

N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.

Yin Y, Xu L, Chang Y, Zeng T, Chen X, Wang A, Groth J, Foo WC, Liang C, Hu H, Huang J. Yin Y, et al. Mol Cancer. 2019 Jan 18;18(1):11. doi: 10.1186/s12943-019-0941-2. Mol Cancer. 2019. PMID: 30657058 Free PMC article.

10

Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46.

Liu YN, Niu S, Chen WY, Zhang Q, Tao Y, Chen WH, Jiang KC, Chen X, Shi H, Liu A, Li J, Li Y, Lee YC, Zhang X, Huang J. Liu YN, et al. Clin Cancer Res. 2019 Jul 1;25(13):4128-4140. doi: 10.1158/1078-0432.CCR-18-3239. Epub 2019 Apr 8. Clin Cancer Res. 2019. PMID: 30962287 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

989 results

Search Page

Filters